Relay Therapeutics, Inc. - Laporan Laba Rugi (TTM)

Relay Therapeutics, Inc.
US ˙ NasdaqGM ˙ US75943R1023

Laporan Laba Rugi (TTM)

Laporan Laba Rugi Relay Therapeutics, Inc. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 83 84 84 85 3 2 2 2 1 1 1 26 26 35 35 10 10 8 8
Change (%) 1.15 1.01 0.79 -96.44 -17.60 -19.19 -15.96 -18.53 -13.98 -20.71 2,638.85 -0.98 38.29 -0.34 -71.58 0.01 -23.26 8.80
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 97 9 32 51 169 190 206 230 243 203 302 316 326 326 330 325 315 307 276
Change (%) -90.76 263.21 56.05 234.96 12.42 8.07 11.84 5.58 -16.49 48.75 4.83 3.14 -0.13 1.16 -1.48 -2.91 -2.72 -9.95
% of Revenue 116.86 10.67 38.37 59.41 5,592.21 7,629.53 10,203.12 13,578.64 17,596.31 17,081.90 32,044.06 1,226.55 1,277.64 922.70 936.59 3,246.84 3,152.20 3,995.92 3,307.32
Gross Operating Profit -14 75 52 35 -166 -188 -204 -228 -242 -202 -230 -219 -301 -291 -295 -315 -305 -299 -268
Change (%) -635.95 -30.31 -33.62 -581.54 12.97 8.43 12.11 5.76 -16.50 13.85 -4.47 37.11 -3.39 1.35 6.90 -3.00 -2.05 -10.43
% of Revenue -16.86 89.33 61.63 40.59 -5,492.21 -7,529.53 -10,103.12 -13,478.64 -17,496.31 -16,981.90 -24,382.27 -850.45 -1,177.64 -822.70 -836.59 -3,146.84 -3,052.20 -3,895.92 -3,207.32
SG&A 42 50 58 63 60 63 66 65 69 73 75 78 79 79 79 80 80 79 73
Change (%) 19.06 16.78 8.40 -5.30 5.58 4.83 -1.58 6.53 5.06 3.65 3.19 0.87 0.28 0.02 1.60 0.19 -1.32 -8.07
% of Revenue 50.65 59.61 68.92 74.12 1,972.53 2,527.28 3,278.38 3,839.59 5,020.13 6,131.23 8,014.23 301.96 307.61 223.06 223.87 800.37 801.84 1,031.12 871.25
R&D 97 97 97 71 71 71
Change (%) 0.00 0.00 0.00 0.00
% of Revenue 115.53 114.37 113.48 5,995.96 7,561.78 276.09
OpEx 138 155 187 210 229 254 272 295 312 347 377 394 405 405 409 405 396 386 349
Change (%) 12.21 20.50 12.31 8.98 10.64 7.26 8.57 5.79 11.10 8.74 4.51 2.69 -0.05 0.94 -0.88 -2.29 -2.44 -9.56
% of Revenue 167.51 185.81 221.67 247.01 7,564.74 10,156.81 13,481.51 17,418.23 22,616.44 29,209.09 40,058.28 1,528.50 1,585.25 1,145.76 1,160.46 4,047.21 3,954.04 5,027.05 4,178.58
Operating Income -56 -72 -103 -125 -226 -251 -270 -294 -311 -346 -376 -369 -379 -369 -373 -395 -386 -378 -341
Change (%) 28.58 43.22 21.79 80.69 11.02 7.52 8.76 5.93 11.21 8.85 -2.09 2.95 -2.63 1.06 5.78 -2.35 -1.90 -9.93
% of Revenue -67.51 -85.81 -121.67 -147.01 -7,464.74 -10,056.81 -13,381.51 -17,318.23 -22,516.44 -29,109.09 -39,958.28 -1,428.50 -1,485.25 -1,045.76 -1,060.46 -3,947.21 -3,854.04 -4,927.05 -4,078.58
Interest Expense
Change (%)
% of Revenue
Net Income -52 -70 -236 -261 -364 -384 -267 -290 -291 -323 -344 -326 -342 -329 -323 -345 -338 -333 -312
Change (%) 33.00 239.10 10.47 39.34 5.46 -30.39 8.74 0.02 11.08 6.73 -5.35 4.91 -3.76 -1.91 6.93 -2.17 -1.28 -6.55
% of Revenue -63.41 -83.38 -279.91 -306.80 -12,012.94 -15,373.96 -13,243.63 -17,136.40 -21,036.13 -27,163.47 -36,562.53 -1,263.49 -1,338.66 -931.64 -916.92 -3,449.92 -3,374.72 -4,341.53 -3,728.89

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista